QV Bioelectronics

Medical Devices
Early Stage

QV Bioelectronics is developing a medical device that will extend the lives of people with terminal brain cancer (glioblastoma). It was founded by Dr. Chris Bullock and Dr. Richard Fu and they are based at Alderley Park. They are producing a working prototype of their implant and are in the process of executing their development strategy towards a first-in-man clinical trial.

Glioblastoma is one of the most aggressive cancers yet there have been precious few treatment innovations over the decades. We invested in QV Bioelectronics because they bring together Manchester’s leadership position in advanced materials with the know-how of some of the UK’s most pre-eminent neurosurgeons to reimagine the use of electrotherapy – a new modality to treat cancer - in a way that will turn the tide on this devastating disease.

Our Approach

What do we look for?

Our business is about forming long term relationships with exceptional entrepreneurs and becoming a trusted partner and supportive investor.

We look for companies with both the vision and potential to become ‘game changers’ and market leaders across a range of sectors.

learn more

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
LE19 4XT

Tel: 0116 238 8200